Literature DB >> 9475831

Use and abuse of flunitrazepam.

M M Simmons1, M J Cupp.   

Abstract

Flunitrazepam is not available in the US, and it is presently illegal to import it. Flunitrazepam has no therapeutic advantage over benzodiazepines presently marketed in the US. Its quick onset of sedation, amnesic properties, and additive effects with alcohol have led to its reputation as a party drug, club drug, or date rape drug. Several measures have been undertaken to curb its illicit use. It is unclear whether flunitrazepam poses a greater public health risk than other benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9475831     DOI: 10.1345/aph.17027

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  5 in total

1.  All solid-state miniaturized potentiometric sensors for flunitrazepam determination in beverages.

Authors:  Mahmoud A Tantawy; Ekram H Mohamed; Ali M Yehia
Journal:  Mikrochim Acta       Date:  2021-05-19       Impact factor: 5.833

2.  Alcohol and medication interactions.

Authors:  R Weathermon; D W Crabb
Journal:  Alcohol Res Health       Date:  1999

3.  Forensic analysis of beverage stains using hyperspectral imaging.

Authors:  Binu Melit Devassy; Sony George
Journal:  Sci Rep       Date:  2021-03-22       Impact factor: 4.379

Review 4.  Early Detection of Prescription Drug Abuse Using Doctor Shopping Monitoring From Claims Databases: Illustration From the Experience of the French Addictovigilance Network.

Authors:  Thomas Soeiro; Clémence Lacroix; Vincent Pradel; Maryse Lapeyre-Mestre; Joëlle Micallef
Journal:  Front Psychiatry       Date:  2021-05-17       Impact factor: 4.157

Review 5.  Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice.

Authors:  Bernardo Dell'Osso; Umberto Albert; Anna Rita Atti; Claudia Carmassi; Giuseppe Carrà; Fiammetta Cosci; Valeria Del Vecchio; Marco Di Nicola; Silvia Ferrari; Arianna Goracci; Felice Iasevoli; Mario Luciano; Giovanni Martinotti; Maria Giulia Nanni; Alessandra Nivoli; Federica Pinna; Nicola Poloni; Maurizio Pompili; Gaia Sampogna; Ilaria Tarricone; Sarah Tosato; Umberto Volpe; Andrea Fiorillo
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-30       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.